Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute myeloid leukemia”
AML2003 - Standard-Therapy vs Intensified Therapy for Adult Acute Myeloid Leukemia Patients <= 60 Years
ClinicalTrials.gov study NCT00180102. IPD Sharing: Not stated. Countries: 1. Publications: 8.
A Study of RO6870810/TEN-010 in Participants With Acute Myeloid Leukemia and Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02308761. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Role of the Therapy Tailored to Risk Factors in Treating Adult Patients (≤60) With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02072811. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Oral PCLX-001 in R/R Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06613217. IPD Sharing: NO. Countries: 1. Publications: 3.
Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00005801. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03874052. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05183035. IPD Sharing: NO. Countries: 20. Publications: 1.
A Safety Study of SGN-CD123A in Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02848248. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Therapy of Acute Myeloid Leukemia in Patients Over the Age of 60 : DA Versus Mitoxantrone With Intermittent AraC
ClinicalTrials.gov study NCT00180167. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Maintenance Therapy With Ceplene® (Histamine) and IL-2 on Immune Response and MRD in Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01347996. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study
ClinicalTrials.gov study NCT00715637. IPD Sharing: Not stated. Countries: 23. Publications: 2.
Study of Decitabine Alone or in Combination With Valproic Acid and All-trans Retinoic Acid in Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00867672. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
ClinicalTrials.gov study NCT03422731. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00091234. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03586609. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Venetoclax in Combination With Chemotherapy in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Leukemia of Ambiguous Lineage
ClinicalTrials.gov study NCT03194932. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Phase Ib Study of Panobinostat (LBH589) in Combination With 5-Azacitidine for Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) Patients
ClinicalTrials.gov study NCT01613976. IPD Sharing: Not stated. Countries: 1. Publications: 1.
FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT07283094. IPD Sharing: NO. Countries: 0. Publications: 24.
A Study Evaluating the Safety and Pharmacokinetics of ABBV-744 in Participants With Relapsed/Refractory Acute Myeloid Leukemia (AML) Cancer
ClinicalTrials.gov study NCT03360006. IPD Sharing: NO. Countries: 1. Publications: 2.
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01515527. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.